WEBCAST OF PRESENTATION BY ELEKTA'S CEO TOMAS PUUSEPP ON FEBRUARY 6

 | Source: Elekta AB Elekta AB 

WEBCAST OF PRESENTATION BY ELEKTA'S CEO TOMAS PUUSEPP ON FEBRUARY 6

Investor information
Stockholm, Sweden, February 5, 2008

On February 6, Tomas Puusepp, President & CEO of Elekta will present at Merrill
Lynch Global Pharmaceuticals, Biotechnology & Medical Devices Conference in New
York.

The presentation by Mr Puusepp will be held at 9.20-10.00am ET (15.20-16.00 CET)
and an audio only live webcast of the presentation and Q&A session will be
available on: 

http://www.veracast.com/webcasts/ml/globalpharma08/45203401.cfm 

This link will be live just prior to the start of the presentation and will be
available for on-demand replay within 24 hours. 

Please note:
To access the webcast presentation, you will need Windows Media Player and/or
Real Player installed on your computer. This event requires that you register
prior to accessing any of the webcasts and requires that you have 'cookies'
enabled on your browser. 



******

For further information, please contact:

ir@elekta.com  
About Elekta

Elekta is an international medical technology group, providing oncologists,
radiation therapists, neurosurgeons and many other medical specialists with
state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and
information systems as well as services for improved cancer care and management
of brain disorders. 

Elekta's systems and solutions are used in over 4,500 hospitals around the
world. Clinical and information management solutions include, among others,
Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta
Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy
and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR
and efficient management of clinical and patient data.

With over 2,000 employees globally, the corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Nordic Exchange under the
ticker EKTAb. More information about Elekta can be found at www.elekta.com.
GlobeNewswire